For UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES
OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Health Sciences Acquisitions Corporation
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 83-2771572 | |||
| (State of Incorporation | (I.R.S. Employer | |||
| or Organization) | Identification No.) |
412 West 15th Street, Floor 9
New York, NY 10011
(Address of Principal Executive Offices)
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of Each Class to be so Registered |
Name of Each Exchange on Which Each Class is to be Registered | |
| Common Stock, $0.0001 par value | The NASDAQ Stock Market LLC | |
| Warrants | The NASDAQ Stock Market LLC | |
| Units | The NASDAQ Stock Market LLC | |
| If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒ | ||
| If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐ | ||
| If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐ | ||
Securities Act registration statement file number to which this form relates: 333-230893.
Securities to be registered pursuant to Section 12(g) of the Act: None.
| Item 1. | Description of Registrant's Securities to be Registered. |
A description of the common stock, warrants and units to be registered hereunder is contained in the section entitled “Description
of Securities” in the Prospectus included in Health Sciences Acquisitions Corporation’s (the “Registrant”)
Registration Statement on Form S-1 (Registration No. 333-230893) initially filed with the Securities and Exchange Commission on
April 16, 2019, as amended from time to time (the “Registration Statement”). This information is incorporated herein
by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and
that are filed subsequently to the Registration Statement are hereby also incorporated by reference herein.
| Item 2. | Exhibits. |
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| Date: May 8, 2019 | HEALTH SCIENCES ACQUISITIONS CORPORATION | ||
| By: | /s/ Roderick Wong, MD | ||
| Name: | Roderick Wong, MD | ||
| Title: | President | ||
3